NASDAQ:EXPO - Exponent Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$50.45 +0.10 (+0.20 %)
(As of 07/19/2018 04:00 PM ET)
Previous Close$50.35
Today's Range$50.05 - $50.70
52-Week Range$31.73 - $52.63
Volume242,600 shs
Average Volume199,138 shs
Market Capitalization$2.61 billion
P/E Ratio47.15
Dividend Yield1.04%
Exponent logoExponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Management consulting services
Sub-IndustryResearch & Consulting Services
SectorBusiness Services


Debt-to-Equity RatioN/A
Current Ratio4.39
Quick Ratio4.39


Trailing P/E Ratio47.15
Forward P/E Ratio40.04
P/E GrowthN/A

Sales & Book Value

Annual Sales$347.80 million
Price / Sales7.54
Cash Flow$1.2503 per share
Price / Cash40.35
Book Value$5.60 per share
Price / Book9.01


EPS (Most Recent Fiscal Year)$1.07
Net Income$41.30 million
Net Margins12.52%
Return on Equity19.47%
Return on Assets13.37%


Outstanding Shares52,010,000
Market Cap$2,605.65

Exponent (NASDAQ:EXPO) Frequently Asked Questions

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Friday, April 20th. Investors of record on Friday, June 8th will be paid a dividend of $0.26 per share on Friday, June 22nd. This represents a $1.04 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date is Thursday, June 7th. View Exponent's Dividend History.

When did Exponent's stock split? How did Exponent's stock split work?

Shares of Exponent split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly minted shares were distributed to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) released its quarterly earnings data on Thursday, April, 19th. The business services provider reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.16 by $0.03. The business services provider earned $96.50 million during the quarter, compared to analyst estimates of $87.54 million. Exponent had a net margin of 12.52% and a return on equity of 19.47%. Exponent's revenue was up 14.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.15 earnings per share. View Exponent's Earnings History.

When is Exponent's next earnings date?

Exponent is scheduled to release their next quarterly earnings announcement on Thursday, July, 19th 2018. View Earnings Estimates for Exponent.

What price target have analysts set for EXPO?

2 brokers have issued 12 month price targets for Exponent's stock. Their forecasts range from $23.75 to $24.00. On average, they anticipate Exponent's stock price to reach $23.8750 in the next year. This suggests that the stock has a possible downside of 52.7%. View Analyst Ratings for Exponent.

What is the consensus analysts' recommendation for Exponent?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

What are Wall Street analysts saying about Exponent stock?

Here are some recent quotes from research analysts about Exponent stock:
  • 1. According to Zacks Investment Research, "Exponent, Inc., is a multidisciplinary organization of scientists, physicians, engineers and business consultants performing in-depth scientific research and analysis in over 90 technical disciplines. The company is an engineering and scientific consulting firm providing solutions to complex problems. The firm has been best known for analyzing accidents and failures to determine their causes, but in recent years it has become more active in assisting clients with human health, environmental and engineering issues associated with new products to help prevent problems in the future. The Company serves clients in the automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors. " (6/20/2018)
  • 2. Cantor Fitzgerald analysts commented, "Foresi’s Take. Exponent posted strong revenue growth in the mid-teens, driven by a large project and strong performance in a number of other areas as well. The company noted new significant work starting to flow into the Environmental and Health practice, due to public concern about chemicals affecting ecosystems and human health. Management stated that a large project in the Human Factors practice had higher-than-expected revenues (7% of revenues), but may begin to roll off somewhat in 2018, estimating that this project could constitute 4-5% of revenues at the end of 2018. Full-year utilization is expected to decline by 1-1.5% from last year, and EBITDA margins were guided to decline by 50-100bps y/y." (4/20/2018)

Are investors shorting Exponent?

Exponent saw a increase in short interest in June. As of June 15th, there was short interest totalling 1,295,517 shares, an increase of 138.8% from the May 31st total of 542,490 shares. Based on an average trading volume of 376,158 shares, the days-to-cover ratio is presently 3.4 days. Currently, 2.5% of the company's stock are sold short. View Exponent's Current Options Chain.

Who are some of Exponent's key competitors?

Who are Exponent's key executives?

Exponent's management team includes the folowing people:
  • Dr. Paul R. Johnston, Exec. Chairman (Age 64)
  • Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 49)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 52)
  • Dr. Harri K. Kytomaa, Group VP of Engineering Sciences & Principal Engineer (Age 59)
  • Dr. Steven J. Murray, Group VP of Mechanics & Materials and Principal Engineer (Age 43)

Has Exponent been receiving favorable news coverage?

News articles about EXPO stock have trended somewhat negative this week, according to Accern. Accern identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Exponent earned a daily sentiment score of -0.03 on Accern's scale. They also assigned press coverage about the business services provider an impact score of 46.91 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the next several days.

Who are Exponent's major shareholders?

Exponent's stock is owned by a number of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.63%), Confluence Investment Management LLC (0.07%), Willow Creek Wealth Management Inc. (0.06%), Louisiana State Employees Retirement System (0.04%), Cordasco Financial Network (0.04%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Exponent stock include Catherine Corrigan, Debra Zumwalt, Harri Kytomaa, John Pye, Michael R Gaulke, Paul Boehm, Paul R Johnston, Richard L Schlenker Jr, Sally Shepard, Stephen C Riggins and Steven J Murray. View Institutional Ownership Trends for Exponent.

Which major investors are buying Exponent stock?

EXPO stock was acquired by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Confluence Investment Management LLC, Willow Creek Wealth Management Inc., Louisiana State Employees Retirement System, Cordasco Financial Network, State of Alaska Department of Revenue, Bank of Montreal Can and Amalgamated Bank. View Insider Buying and Selling for Exponent.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $50.45.

How big of a company is Exponent?

Exponent has a market capitalization of $2.61 billion and generates $347.80 million in revenue each year. The business services provider earns $41.30 million in net income (profit) each year or $1.07 on an earnings per share basis. Exponent employs 1,075 workers across the globe.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]

MarketBeat Community Rating for Exponent (NASDAQ EXPO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  136 (Vote Outperform)
Underperform Votes:  141 (Vote Underperform)
Total Votes:  277
MarketBeat's community ratings are surveys of what our community members think about Exponent and other stocks. Vote "Outperform" if you believe EXPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EXPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.